SCHEMBL2566529

SCHEMBL2566529

COCC(COC)(NC(=O)Oc1ccc(Cl)s1)C(=O)Nc1ccc2c(c1)CCN(C)CC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
DRD2 P14416 3/20 0.35
HTR2C P28335 3/20 0.35
DRD3 P35462 3/20 0.35
HTR6 P50406 3/20 0.35
NPSR1 Q6W5P4 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
CYP3A4 P08684 2/20 0.34
HTR2A P28223 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2569948 0.91 MEN1 (0.36) MEN1KMT2AHDAC1HDAC2DRD2
SCHEMBL2571305 0.90 KDM4E (0.36) KDM4EHDAC1HDAC2DRD2HTR2C
SCHEMBL2569548 0.88 AR (0.34) MEN1KMT2AHDAC1HDAC2DRD2
SCHEMBL3023542 0.86 F10 (0.45) KDM4EMEN1KMT2AF10AR
SCHEMBL2571214 0.85 KDM4E (0.40) KDM4EHDAC1HDAC2DRD2HTR2C
SCHEMBL13070159 0.85 F10 (0.39) KDM4EKMT2ADRD2HTR2CDRD3
SCHEMBL2568969 0.84 RAB9A (0.36) MEN1KMT2AHDAC1HDAC2DRD2
SCHEMBL2571863 0.81 RAB9A (0.34) MEN1KMT2AHDAC1HDAC2DRD2
SCHEMBL2568110 0.81 HDAC1 (0.34) MEN1KMT2AHDAC1HDAC2DRD2
SCHEMBL2568026 0.80 PSEN1 (0.33) KDM4EHDAC1HDAC2DRD2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP disclosed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP disclosed